- $1.40bn
- $2.25bn
- $1.31bn
- 92
- 78
- 51
- 87
Annual balance sheet for Conmed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 27.4 | 20.8 | 28.9 | 24.3 | 24.5 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 177 | 184 | 191 | 242 | 238 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 417 | 460 | 581 | 616 | 640 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 133 | 128 | 133 | 137 | 156 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,752 | 1,766 | 2,298 | 2,300 | 2,306 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 190 | 197 | 297 | 311 | 278 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,043 | 981 | 1,552 | 1,466 | 1,344 |
| Non Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 709 | 785 | 746 | 834 | 963 |
| Total Liabilities & Shareholders' Equity | 1,752 | 1,766 | 2,298 | 2,300 | 2,306 |
| Total Common Shares Outstanding |